[{"command":"openDialog","selector":"#drupal-modal","settings":null,"data":"\u003Cdiv id=\u0022republish_modal_form\u0022\u003E\u003Cform class=\u0022modal-form-example-modal-form ecl-form\u0022 data-drupal-selector=\u0022modal-form-example-modal-form\u0022 action=\u0022\/en\/article\/modal\/6462\u0022 method=\u0022post\u0022 id=\u0022modal-form-example-modal-form\u0022 accept-charset=\u0022UTF-8\u0022\u003E\u003Cp\u003EHorizon articles can be republished for free under the Creative Commons Attribution 4.0 International (CC BY 4.0) licence.\u003C\/p\u003E\n \u003Cp\u003EYou must give appropriate credit. We ask you to do this by:\u003Cbr \/\u003E\n 1) Using the original journalist\u0027s byline\u003Cbr \/\u003E\n 2) Linking back to our original story\u003Cbr \/\u003E\n 3) Using the following text in the footer: This article was originally published in \u003Ca href=\u0027#\u0027\u003EHorizon, the EU Research and Innovation magazine\u003C\/a\u003E\u003C\/p\u003E\n \u003Cp\u003ESee our full republication guidelines \u003Ca href=\u0027\/horizon-magazine\/republish-our-stories\u0027\u003Ehere\u003C\/a\u003E\u003C\/p\u003E\n \u003Cp\u003EHTML for this article, including the attribution and page view counter, is below:\u003C\/p\u003E\u003Cdiv class=\u0022js-form-item form-item js-form-type-textarea form-item-body-content js-form-item-body-content ecl-form-group ecl-form-group--text-area form-no-label ecl-u-mv-m\u0022\u003E\n \n\u003Cdiv\u003E\n \u003Ctextarea data-drupal-selector=\u0022edit-body-content\u0022 aria-describedby=\u0022edit-body-content--description\u0022 id=\u0022edit-body-content\u0022 name=\u0022body_content\u0022 rows=\u00225\u0022 cols=\u002260\u0022 class=\u0022form-textarea ecl-text-area\u0022\u003E\u003Ch2\u003EHave the courage to move outside your comfort zone \u2013 Prof. Hans Clevers\u003C\/h2\u003E\u003Cp\u003E\u003Cstrong\u003EYou\u2019re known for your work growing miniature replica organs, known as organoids, from adult stem cells in the lab. \u003C\/strong\u003E\u003Cstrong\u003EWhat kinds of applications does this have?\u003C\/strong\u003E\u003C\/p\u003E\u003Cp\u003E\u2018In the long run, replacements for organ transplants. These mini-organs are very, very small, we can produce billions of them and they are really very healthy stem cells. So you can put them back in (the body) and they can repair a damaged or sick organ. We have shown this for liver and gut (in mice), but we think we can do it in any organ. We know that we can scale up to the size that we need for humans; we know that if we transplant the cells to mice they will take.\u003C\/p\u003E\u003Cp\u003E\u2018(However), it is going to be years before we will be allowed to test this on humans. We still have to (work with) the regulatory authorities to find out what would be the hoops that we have to jump through to prove that there is no safety issue. The other thing is that optimal transplantation routes have never been determined in humans. We are not transplanting an organ, we are transplanting cells into a sick organ, and there is very little experience with this. In mice we can do it, but we have to work with clinicians to find out the best way to deliver.\u2019\u003C\/p\u003E\u003Cp\u003E\u003Cstrong\u003EAny shorter-term applications?\u003C\/strong\u003E\u003C\/p\u003E\u003Cp\u003E\u003Cblockquote class=\u0022tw-text-center tw-text-blue tw-font-bold tw-text-2xl lg:tw-w-1\/2 tw-border-2 tw-border-blue tw-p-12 tw-my-8 lg:tw-m-12 lg:tw--ml-16 tw-float-left\u0022\u003E\n \u003Cspan class=\u0022tw-text-5xl tw-rotate-180\u0022\u003E\u201c\u003C\/span\u003E\n \u003Cp class=\u0022tw-font-serif tw-italic\u0022\u003E\u2018If you exude trust you\u2019ll receive trust and everything becomes much easier.\u2019\u003C\/p\u003E\n \u003Cfooter\u003E\n \u003Ccite class=\u0022tw-not-italic tw-font-normal tw-text-sm tw-text-black\u0022\u003EProf. Hans Clevers, Hubrecht Institute, the Netherlands\u003C\/cite\u003E\n \u003C\/footer\u003E\n\u003C\/blockquote\u003E\n\u2018In the short run we are already helping patients. We can take cells out of a diseased tissue and grow them and then use the cells as an avatar of the patient. For instance, cystic fibrosis. There are fantastic drugs (to treat it), but it is very unpredictable who will respond (to them). We have a very simple test, we take a small rectal biopsy and a week later we have enough mini-colons to do the test. The Dutch Ministry of Health has recently agreed that every time we identify a patient that will respond to the drug, insurance companies will pay for the drug. We have quite a few (people) now that were not going to be given the drug because they were in a rare class of cystic fibrosis patients, but based on our (test) they got the drug and it works.\u003C\/p\u003E\u003Cp\u003E\u2018We\u2019re trying to do the same thing for cancer. So we can grow normal tissue and cancer tissue from the same patient. And the situation is the same, you never know when you give a drug to a patient (whether it\u2019s going to work). Statistically, the chance is that 30 % of them work, on average, but you never know which patient will respond and which will not respond to the cancer drug. (We want to) ascertain how we prove that by growing tumours and by exposing them to drugs, you can actually predict what will be a good drug for a patient. That\u2019s ongoing.\u2019\u003C\/p\u003E\u003Cp\u003E\u003Cstrong\u003ECan you tell us a little bit about how you were able to create these organoids in the first place?\u003C\/strong\u003E\u003C\/p\u003E\u003Cp\u003E\u2018Sort of by chance about 15 to 20 years ago we discovered an important component of what\u2019s called the Wnt pathway \u2013 small proteins that are used extensively during development. It turns out that these signals are crucial to maintaining a variety of different adult stem cells.\u003C\/p\u003E\u003Cp\u003E\u2018We then actually discovered a number of novel types of stem cells. The bone marrow stem cells were very well known as adult stem cells, skin stem cells were known, but for most organs they were not known. We found a marker which is on the surface of a variety of different types of adult stem cells. And that\u2019s how we found the most active stem cell in our body, which is the stem cell of the gut.\u003C\/p\u003E\u003Cp\u003E\u2018We made a mouse in which these stem cells made light so we can see them in action, make movies of how they act. And we said, if these stem cells can do this in vivo, in a mouse, it should be possible to do this in vitro (in the lab).\u003C\/p\u003E\u003Cp\u003E\u2018And what we got was very surprising. A single stem cell builds a mini version of a gut. Everything you\u2019ll see in a gut is there. So these mini-guts really represent the real organ.\u003C\/p\u003E\u003Cp\u003E\u2018We then moved to human tissues and it turned out to be possible to grow human gut as easily as mouse gut. And then we turned to other tissue \u2013 liver, pancreas, lung, breast, skin \u2013 and in all cases we managed to find stem cells that we could put in a culture and then create organs in essence. The only one we cannot (grow) at the moment is the heart.\u2019\u003C\/p\u003E\u003Cp\u003E\u003Cstrong\u003EYou\u2019ve received funding from the EU to work more on organoids through the Wnt and CRC, Organoid and suppresSTEM projects. What are you trying to do there?\u003C\/strong\u003E\u003C\/p\u003E\u003Cp\u003E\u2018We try to take the gut organoids to the next level. There are two branches. One is (looking at) the microbiome \u2013 all the bacteria in our gut, which are hundreds of species. What we are doing currently is one-by-one injecting bacterial species from the normal microbiome, but also from the non-healthy microbiome, into human mini-guts. In these mini-guts there is no immune system, there is only the epithelium, the inner lining. We see where (the bacteria) go, we see what they look like, we see with what cells in the gut they interact, what changes they induce, very basic observations. We hope to find a few (interesting) species and then we\u2019ll delve in deeper.\u003C\/p\u003E\u003Cp\u003E\u2018The other is colon cancer. We are growing the colon cancers and also we are growing new cells from that cancer. These tumours are full of lymphocytes (white blood cells from the immune system). But the lymphocytes don\u2019t kill the tumour. So we\u2019re trying to reconstitute these lymphocytes with the cultured tumours, put them under the microscope, see why they don\u2019t kill and how we can start encouraging them to kill the cancer cells. I think that this is a unique opportunity to take all the immunology experience and combine it with our tumour organoids.\u2019\u003C\/p\u003E\u003Cp\u003E\u003Cstrong\u003EYou\u2019ve mentioned that you will use some of the EUR 750 000 \u003C\/strong\u003E\u003Cstrong\u003EK\u00f6rber\u0026nbsp;\u003C\/strong\u003E\u003Cstrong\u003Eprize for gene therapy. Can you explain a bit about this?\u003C\/strong\u003E\u003C\/p\u003E\u003Cp\u003E\u2018For cystic fibrosis we have already shown that (using gene editing technology) CRISPR-Cas9 it is very simple to repair the gene. So you take a little bit of a tissue from a patient, and (set up a culture and) you see where the mistake is in the DNA which can now be corrected. And you can grow billions of stem cells that are identical to the patient\u2019s but no longer have the genetic disease. The next step is to transplant them to the original patient.\u2019\u003C\/p\u003E\u003Cp\u003E\u003Cstrong\u003EThe \u003C\/strong\u003E\u003Cstrong\u003EK\u00f6rber\u0026nbsp;\u003C\/strong\u003E\u003Cstrong\u003Eprize is the latest in a long line of awards for your research. What advice would you give to young researchers about the secret of success?\u003C\/strong\u003E\u003C\/p\u003E\u003Cp\u003E\u2018For me it has been that I have never been afraid of moving fields. So if you have a good idea and it is not exactly in the field of your comfort zone, have the courage to move out of your comfort zone and start working on a different organ or a different disease. In the end, science is science.\u003C\/p\u003E\u003Cp\u003E\u2018The second thing is that many (young people) come with this idea that you have to be very secretive about your discoveries, you don\u2019t share because people will steal. From the beginning I decided that I didn\u2019t want to work in a world where distrust is the norm, I want to work in a world where we are open and we can share. I actually find that if you exude trust you\u2019ll receive trust and everything becomes much easier. And now it is very easy for me to find collaborators around the world because everybody knows you work with this lab and they\u2019ll never play tricks, they\u2019ll be open and tell us everything we need to know. And also it\u2019s much more fun.\u2019\u003C\/p\u003E\u003C\/textarea\u003E\n\u003C\/div\u003E\n\n \u003Cdiv id=\u0022edit-body-content--description\u0022 class=\u0022ecl-help-block description\u0022\u003E\n Please copy the above code and embed it onto your website to republish.\n \u003C\/div\u003E\n \u003C\/div\u003E\n\u003Cinput autocomplete=\u0022off\u0022 data-drupal-selector=\u0022form-lpnq8evpwtqnk9ezxiho9fosyxlmvf3gdmj-4qj2mjo\u0022 type=\u0022hidden\u0022 name=\u0022form_build_id\u0022 value=\u0022form-lpnQ8evPwTQNk9eZXIHO9FoSYxlMVF3GdmJ_4QJ2MJo\u0022 \/\u003E\n\u003Cinput data-drupal-selector=\u0022edit-modal-form-example-modal-form\u0022 type=\u0022hidden\u0022 name=\u0022form_id\u0022 value=\u0022modal_form_example_modal_form\u0022 \/\u003E\n\u003C\/form\u003E\n\u003C\/div\u003E","dialogOptions":{"width":"800","modal":true,"title":"Republish this content"}}]